View drug registration information details.
Items | Registration information |
ID | 1642 |
No | 1642 |
Brand Name | CAPANIB |
Ingredients | CAPMATINIB 200 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 56'S/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | Used for the treatment of adult patients with metastatic, non-small cell lung cancer (NSCLC) whose tumors have tested positive for a mutation that leads to MET exon 14 skipping |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | REDDISH BROWN TABLET |
Note | |
License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 11 L 0934/22 |
FDD Registration Date | 06-DEC-2022 |
Expiry Date | 05-DEC-2025 |
Back to drug list
|